Medication info

Prohylon Injection (Sodium Hyaluronate) (Pre-filled)

Prescription medicationInjection
Ingredient · strength
Sodium Hyaluronate›15mg / 1mL
Manufacturer / importer
Mothers Pharmaceuticals Co., Ltd.
Appearance
A colorless, transparent, viscous liquid contained within a glass vial sealed with rubber stoppers (part of the pre-filled syringe system).
Packaging
0.85mL/vial
Approval status
Active

MFDS item code 201607310 · Notified 2016.12.28 · Insurance code 622804491

Summary

Main use
Adjunctive treatment in ophthalmic surgery (cataract, corneal transplantation, glaucoma, etc.)
Who receives it
Adults
Adult administration
1. Cataract surgery and intraocular lens implantation Slowly inject the required amount of this medicine into the anterior chamber of the eye using a needle or cannula, before or after removal of the lens. Inject it before cataract extraction or intraocular lens insertion and before cataract surgery, both extracapsular and intracapsular, as its corneal endothelial protective effect as an adjunct may be optimal only when administered before cataract extraction or intraocular lens insertion. This medicine may be used to coat surgical instruments and the intraocular lens to be implanted. 2. Corneal transplantation After removing the corneal graft, fill the anterior chamber with this medicine until its level is flush with the corneal surface. Place the donor graft over this medicine and suture it. 3. Glaucoma filtration surgery Inject this medicine through a corneal paracentesis to replenish and maintain the volume of the anterior chamber during trabeculectomy.

Ingredients

Manufacturer
Mothers Pharmaceuticals Co., Ltd.

Efficacy & effects

Adjunctive treatment in ophthalmic surgery (cataract, corneal transplantation, glaucoma, etc.)

View approved original text

This medication is used as an auxiliary during various ophthalmic surgical procedures such as cataract surgery, corneal transplantation, and glaucoma surgery when implanting the lens. It plays an important role in enhancing surgical safety and aiding recovery.

How it is given

Adult administration

1. Cataract surgery and intraocular lens implantation Slowly inject the required amount of this medicine into the anterior chamber of the eye using a needle or cannula, before or after removal of the lens. Inject it before cataract extraction or intraocular lens insertion and before cataract surgery, both extracapsular and intracapsular, as its corneal endothelial protective effect as an adjunct may be optimal only when administered before cataract extraction or intraocular lens insertion. This medicine may be used to coat surgical instruments and the intraocular lens to be implanted. 2. Corneal transplantation After removing the corneal graft, fill the anterior chamber with this medicine until its level is flush with the corneal surface. Place the donor graft over this medicine and suture it. 3. Glaucoma filtration surgery Inject this medicine through a corneal paracentesis to replenish and maintain the volume of the anterior chamber during trabeculectomy.

Precautions

This medication is an ophthalmic injection containing sodium hyaluronate as the main ingredient, used during eye surgery. First, this medication should not be administered to patients who have had allergic reactions to any components or proteins from pharmaceutical products. There can be various side effects when using this medication, such as increased intraocular pressure or inflammation in the eyes. Additionally, corneal edema or opacification, bleeding, abnormality in the iris can occur, and symptoms such as eye pain, itching, and decrease in vision may arise. Also, due to the phosphate component in this medication, in rare cases, corneal calcification may occur in patients with severely damaged corneas, so caution is necessary. Post-surgery, it is particularly important to meticulously check the intraocular pressure, and if there is an increase, appropriate treatment should be received. It is also advisable to remove this medication as much as possible through irrigation or aspiration after surgery. When performing ultrasound emulsification during surgery, sufficient irrigation fluid should be allowed to flow between the lens and this medication through the aspiration system. When cleaning surgical instruments, solutions containing quaternary ammonium compounds such as benzalkonium chloride should not be used. This medication contains components derived from avian cells, which may trigger immune responses or other risks, so appropriate caution is required. Additionally, it should not be used in conjunction with the drug hyaluronidase. When administering, it is essential to adhere strictly to the prescribed methods and dosages for ophthalmic use, and it must never be injected intravenously. Before usage, the refrigerated medication should be allowed to reach room temperature for approximately 30 minutes to obtain the proper temperature. Caution should be taken as mixing with benalkonium chloride or chlorhexidine may lead to the formation of precipitates. Once opened, the medication should be used once and any remaining product must be discarded along with its container. When using this medication mixed with air, care should be taken to ensure that air does not enter beneath the iris, and administration should be done slowly and cautiously. When injecting into the anterior chamber, care should be taken to avoid overdose, as an overdose may cause elevated intraocular pressure. Finally, this medication should be kept out of reach of children and stored in a cool, dry place, avoiding direct sunlight, preferably in a sealed container. Additionally, to prevent misuse and maintain quality, the medication should not be transferred to another container.

Side effects

Increased intraocular pressure, inflammatory response, corneal swelling, corneal opacity, anterior hyphema, iridal neovascularization, posterior iris ulcer, conjunctival adhesion deficiency, mydriasis, lens opacity, pain, pruritus, blurred vision, corneal dystrophy, opacification of the surface of the intraocular lens, corneal calcification

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container, maintaining a temperature between 2 degrees and 8 degrees. Keep away from direct sunlight in a cool place and avoid freezing.

Appearance and packaging

Appearance

A colorless, transparent, viscous liquid contained within a glass vial sealed with rubber stoppers (part of the pre-filled syringe system).

Package unit

0.85mL/vial

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.